Comparison and Description of Coronary Patients Management With or Without Heart Failure in Cardiology Consulting

AstraZeneca1 个研究点分布在 1 个国家目标入组 1,650 人开始时间: 2008年6月最近更新: 2009年8月6日

适应症

试验速览

阶段: 不适用
状态: 已完成
发起方: AstraZeneca
入组人数: 1,650
试验地点: 1
主要终点: Frequency of attainment control goals through the more represented cardiovascular factor risk, dyslipidemia, among coronary patients with or without heart failure in cardiology consulting.

研究概览研究设计入排标准结局指标研究者研究点记录与标识符相似试验

研究概览

简要总结

The purpose of this observational study is to compare frequency of attainment control goals through the more represented cardiovascular factor risk, dyslipidemia, among coronary patients with or without heart failure in cardiology consulting.

研究设计

研究类型: Observational
观察模型: Cohort
时间视角: Cross Sectional

入排标准

年龄范围: 18 Years 至 —（Adult, Older Adult）
性别: All
接受健康志愿者: 否

入选标准

•patient with coronary disease diagnosed since at least 1 year
•Echocardiography done less than 1 year ago
•patient with or without documented heart failure

排除标准

未提供

结局指标

主要结局

Frequency of attainment control goals through the more represented cardiovascular factor risk, dyslipidemia, among coronary patients with or without heart failure in cardiology consulting.

时间窗: Once

次要结局

未报告次要终点

研究者

发起方

AstraZeneca

申办方类型

Industry

研究点 (1)

Loading locations...

相似试验

进行中（未招募）

不适用

Optimization of Management in Patients With Cardiovascular Disease After Lower Limb Joint ReplacementThromboembolismAnticoagulant-induced Bleeding

NCT06627933I.M. Sechenov First Moscow State Medical University1,733

已完成

不适用

Improving Health Behavior and Outcomes After AngioplastyAngioplasty

NCT00248976Weill Medical College of Cornell University660

已完成

3 期

Drug Compliance and Quality of Life in Patients With Heart Failure Dosed With Either Once-daily or Twice-daily CoregChronic Heart Failure

NCT00272805Cardiovascular Clinical Sciences Inc400

已完成

不适用

Comparative Analysis of Outcomes Among Patients Initiating Xeljanz in Combination With Oral MTX Who Withdraw MTX Versus Continue MTXRheumatoid Arthritis

NCT03975790Pfizer479

Unknown

4 期

Cardiac Resynchronization in Atrial Fibrillation Trial - a Pilot StudyHeart FailureAtrial Fibrillation

NCT01850277National Institute of Cardiology, Warsaw, Poland60